苏格兰将加入联合王国关于青春期阻塞者的研究,将性别服务转向儿科环境,并投资4 400万英镑。 Scotland to join UK-wide study on puberty-blockers, shifting gender services to pediatric settings and investing £4.4M.

在4月禁止新处方之后,苏格兰将参加一项全联合王国范围的研究,研究为治疗性别性抑郁症而抑制青春期的激素。 Scotland will participate in a UK-wide study on puberty-suppressing hormones for treating gender dysphoria, following a ban on new prescriptions in April. 这一决定是在Cass审查发现支持这种治疗的证据不足证据后作出的。 This decision comes after the Cass Review revealed weak evidence supporting such treatments. 儿童性别服务将从桑迪福德诊所转向儿科环境,投资440万英镑用于改善性别认同保健。 Gender services for children will shift from the Sandyford clinic to pediatric settings, with an investment of over £4.4 million for improved gender identity healthcare. 获得这些服务需要门诊医生转诊。 Access to these services will require a clinician's referral.